BIOGEN INC.

BIOGEN INC. has an estimated net worth of $318 Million. This is based on reported shares across multiple companies, which include Sage Therapeutics, Inc., Denali Therapeutics Inc., SANGAMO THERAPEUTICS, INC, Bioverativ Inc., SUNESIS PHARMACEUTICALS INC, TARGETED GENETICS CORP /WA/, REATA PHARMACEUTICALS INC, and Apellis Pharmaceuticals, Inc..

2005 was BIOGEN INC.'s most active year for acquiring shares with 3 total transactions. BIOGEN INC.'s most active month to acquire stocks was the month of August. 2005 was BIOGEN INC.'s most active year for disposing of shares, totalling 106 transactions. BIOGEN INC.'s most active month to dispose stocks was the month of June. 2005 saw BIOGEN INC. paying a total of $5,000,002.00 for 2,912,022 shares, this is the most they've acquired in one year. In 2023 BIOGEN INC. cashed out on 6,000,000 shares for a total of $3,000,000.00, their largest year based on trade value.